Applications will be accepted for 2020 in Fall 2019.
The aim of the Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies, a select group of late-stage private companies, and investors to foster the development of important new medicines that will expand the industry’s pipeline. All presentations are 13 minutes in length.
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics or platform technologies. Service providers will not be considered. Please note, there are registration and presentation fees associated with presenting. Visit our Registration Page for more information.
All final qualifications are determined by BIO. For more information about presentations, visit our FAQ.